Overview

Study of External Beam Radiation Therapy With and Without Hormonal Therapy to Treat Prostate Cancer

Status:
Active, not recruiting

Trial end date:
2021-12-01

Target enrollment:

Participant gender:

Summary

This clinical study was to determine if the use of 6 months of total androgen suppression (hormonal therapy) when added to radiation therapy for localized-high risk prostate cancer would improve overall survival.

Phase:

Phase 3

Details

Lead Sponsor:

Dana-Farber Cancer Institute

Collaborators:

Beth Israel Deaconess Medical Center
Brigham and Women's Hospital
Metro West Medical Center
Saint Anne's Hospital

Treatments:

Androgens
Flutamide
Goserelin